Browse > Article

Effect of Viability and Integrity of Bifidobacterium on Suppression of Allergy in Mice  

Kim Hye-Young (Department of Food and Nutrition, Seoul National University)
Geun Eog-Ji (Department of Food and Nutrition, Seoul National University)
Publication Information
Journal of Microbiology and Biotechnology / v.16, no.7, 2006 , pp. 1010-1016 More about this Journal
Abstract
The effects of the cell viability and integrity of Bifidobacterium on suppression of allergy were investigated. C3H/HeJ mice were sensitized on weeks 3, 4, 6, and 8 with ovalbumin and choleratoxin to induce an allergic reaction. Mice fed 0.2% of live, disrupted, or heat-killed Bifidobacterium bifidum BGN4 in the pellets of their diet for 8 weeks starting 2 weeks before initial sensitization differentially suppressed the allergy response in terms of levels of IgE and IgG1 in their sera, and symptoms on their tails. Viable Bifidobacterium was more effective than disrupted or heat-killed cells in suppressing the allergy. Growth inhibition, which occurred in the sham group at week 4, did not occur in the treated groups. These results show that Bifidobacterium has a suppressive effect on the allergic response of mice, and that the viability and integrity of the Bifidobacterium is required for effective suppression in our experimental model.
Keywords
Food allergy; IgE; Bifidobacterium;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By Web Of Science : 6  (Related Records In Web of Science)
연도 인용수 순위
1 Goldin, B. R., A. H. Lichtenstein, and S. L. Gorbach. 1988. The role of the intestinal flora, pp. 500-512. In Shils, M. E. and V. R. Young (eds.), Modern Nutrition in Health and Disease. LFA and FEBIGER, Philadelphia
2 Halpern, G. M., K. G. Vruwink, J. Van De Water, C. L. Keen, and M. E. Gershwin. 1991. Influence of long-term yoghurt consumption in young adults. Int. J. Immunother. 7: 205-210
3 Hattori, K., A. Yamamoto, M. Sasai, S. Taniuchi, T. Kojima, Y. Kobayashi, H. Iwamoto, K. Namba, and T. Yaeshima. 2003. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 52: 20-30
4 Kim, H. Y., J. H. Yang, and G. E. Ji. 2005. Effect of bifidobacteria on production of allergy-related cytokines from mouse spleen cells. J. Microbiol. Biotechnol. 15: 265-268   과학기술학회마을
5 Modler, H. W., R. C. Mckellar, and N. Yaguchi. 1990. Bifidobacteria and bifidogenic factors. Can. Inst. Food Sci. Technol. J. 23: 29-41   DOI
6 Ouwehand, A. C., P. V. Kirjavainen, C. Shortt, and S. Calminen. 1999. Probiotics: Mechanisms and established effects. Int. Dairy J. 9: 43-52   DOI   ScienceOn
7 Salminen, S., C. Bouley, M. C. Boutron-Ruault, J. H. Cummings, A. Franck, G. R. Gibson, E. Isolauri, M. C. Moreau, M. Roberfroid, and I. Rowland. 1998. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80: S147-S171   DOI   ScienceOn
8 Madara, J. L. 1997. The chameleon within: Improving antigen delivery. Science 277: 910-911   DOI   ScienceOn
9 Kalka-Moll, W. M., A. O. Tzianabos, Y. Wang, V. J. Carey, R. W. Finberg, A. B. Onderdonk, and D. L. Kasper. 2000. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J. Immunol. 164: 719-724   DOI
10 Yoshioka, H., K. lseki, and K. Fujita. 1983. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72: 317-321
11 De Simone, C., R. Vesely, B. B. Salvadori, and E. Jirillo. 1993. The role of probiotics in modulation of the immune system in man and in animals. Int. J. Immunother. 9: 23-28
12 Bjorksten, B., P. Naaber, E. Sepp, and M. Mikelsaar. 1999. The intestinal microflora in allergic Estonian and Swedish 2-year old children. Clin. Exp. Allergy 29: 342-346   DOI
13 Lee, B. H. and G. E. Ji. 2005. Effect of Bifidobacterium cell fractions on IL-6 production in RAW 264.7 macrophage cells. J. Microbiol. Biotechnol. 15: 740-744   과학기술학회마을
14 Kitazawa, H., Y. Tomioka, K. Matsumura, H. Aso, M. Mizugaki, T. Itoh, and T. Yamaguchi. 1994. Expression of mRNA encoding IFN alpha in macrophages stimulated with Lactobacillus gasseri. FEMS Microbiol. Lett. 120: 315-322
15 Namba, Y., Y. Hidaka, K. Taki, and T. Morimoto. 1981. Effect of oral administration of lysozyme or digested bacterial cell walls on immunostimulation in guinea pigs. Infect. Immun. 31: 580-583
16 Kim, I. H., M. S. Park, and G. E. Ji. 2003. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocytelike Caco-2 cells. J. Microbiol. Biotechnol. 13: 276-281   과학기술학회마을
17 Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241   DOI   ScienceOn
18 Kitazawa, H., K. Matsumura, T. Itoh, and T. Yamaguchi. 1992. Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus. Microbiol. Immunol. 36: 311-315   DOI
19 Seikine, K., E. W. Seikine, T. Toida, T. Tatsuki, T. Kawashima, and Y. Hashimato. 1994. Induction and activation of tumoricidal cells in vivo and in vitro by the bacterial cell wall of Bifidobacterium infantis. Bifidobact. Microfl. 13: 65-77   DOI
20 Glen, E. H. and R. S. Lambrecht. 1993. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid producing bacteria. J. Dairy Sci. 76: 2485-2492   DOI   ScienceOn
21 Hotta, M., Y. Saito, S. Iwata, N. Yamashita, K. Sunakawa, T. Olikawa, R. Tanaka, K. Watanabe, H. Takayama, M. Yajima, S. Kekiguchi, S. Arai, T. Sakurai, and M. Mutai. 1987. Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea. Keio J. Med. 36: 298-314   DOI   ScienceOn
22 Sakagami, H., Y. Kuroiwa, M. Takeda, H. Ota, K. Kazama, T. Naoe, Y. Kawazoe, S. Ichikawa, H. Kondo, T. Yokokura, and M. Shikita. 1992. Distribution of TNF endogenously induced by various immunopotentiators and Lactobacillus easel in mice. In Vivo 6: 247-254
23 Kalliomaki, M., P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107: 129-134   DOI   ScienceOn
24 Cleveland, M. G, J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy. 1996. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64: 1906-1912
25 Shida, K., K. Makino, A. Morishita, K. Takamizawa, S. Hachimura, A. Ametani, T. Sato, Y. Kumagai, S. Habu, and S. Kaminogawa. 1998. Lactobacillus casei inhibits antigen induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allergy Immunol. 115: 278-28   DOI   ScienceOn
26 Bourlioux, P., B. Koletzko, F. Guarner, and V. Braesco. 2002. The intestine and its microflora are partners for the protection of the host: Report on the Danone Symposium 'The intelligent intestine,' held in Paris. Am. J. Clin. Nutr. 78: 675-683
27 Matsuzaki, T., R. Yamazaki, S. Hashimoto, and T. Yokokura. 1998. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Sci. 81: 48-53   DOI   ScienceOn
28 Pereyra, B. S., R. Falcoff, E. Falcoff, and D. Lemonnier. 1991. Interferon induction by Lactobacillus bulgaricus and Streptococcus thermophilus in mice. Eur. Cytokine Netw. 2: 299-303
29 Kirjavainen, P. V., E. Apostolou, S. J. Salminen, and E. Isolauri. 1999. New aspects of probiotics - a novel approach in the management of food allergy. Allergy 54: 909-915   DOI   ScienceOn
30 Marinaro, M., P. N. Boyaka, F. D. Finkelman, H. Kiyono, R. J. Jackson, E. Jirillo, and J. R. McGhee. 1997. Oral but not parenteral interleukin-12 redirects T helper 2-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med.185: 415-427   DOI
31 Kubin, M., J. M. Chow, and G. Trinchieri. 1994. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor-$\alpha$, and IL-1 $\beta$ production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83: 1847-1855